Lactobacillus species are the predominant vaginal microbiota found in healthy women of reproductive age and inhibit pathogen growth by producing lactic acid, H 2 O 2 and anti-microbial compounds [1] [2] [3] . Highly diverse Lactobacillus-non-dominant vaginal microbial communities are strongly correlated with genital inflammation, which negatively affects reproductive health and increases the risk of HIV infection 4, 5 . On the other hand, Lactobacillus gasseri-dominant vaginal communities increase the clearance of human papillomavirus 6 . Furthermore, the abundance of Gardnerella or Ureaplasma species, which is related to the risk of preterm birth, is elevated in bacterial communities in which Lactobacillus species are lowly abundant 7 . These findings imply that Lactobacillus species in the vagina are important for preventing infection, clearing pathogenic microbes and modulating inflammation.
Antifungal effects and characterisation of LCSs. The inhibitory effect of the 51 Lactobacillus strains on
C. albicans growth was evaluated in vitro. We prepared LCSs of the lactobacilli isolates. The antifungal activities of the 51 LCSs were assessed and presented according to the rank of activity and adjusted p-values (Fig. 3) . C. albicans growth was inhibited most by the LCS of the L. gasseri strain SNUV281, but was not markedly inhibited by those of the other L. gasseri strains. The LCSs of L. crispatus exhibited higher anti-Candida activity than those of the L. fermentum, L. gasseri and L. jensenii strains.
We selected the L. crispatus SNUV220 and L. fermentum SNUV175 strains for further analysis based on their anti-Candida growth activity and probiotic characteristics, such as resistance to gastric acidity, bile acid resistance and anti-microbial activity. We hypothesised that vaginal Lactobacillus strains secrete pH-independent antifungal compounds that inhibit C. albicans growth. The antifungal activity of the LCSs was evaluated. Treatment with pH-unadjusted LCSs of L. fermentum SNUV175 and L. crispatus SNUV220 decreased C. albicans growth by 43.7% ± 2.7% and 25.07% ± 11.3%, respectively (Fig. 4A ). Both LCSs also inhibited C. albicans growth at neutral pH; LCSs of L. fermentum SNUV175 and L. crispatus SNUV220 decreased C. albicans growth by 74.81% ± 7.215% and 77.42% ± 5.633%, respectively (Fig. 4B) . The inhibitory effect of acidity due to lactate production was also assessed. C. albicans growth was inhibited when the pH was decreased to 4.0 using HCl and to 4.5 using 500 mM L/D-lactate ( Supplementary Fig. S1A,B) . However, C. albicans growth was not affected by L-lactate, D-lactate and L/D-lactate (16.125-500 mM) after adjustment of the pH to 6.9 ( Supplementary Fig. S2C ).
Next, we investigated the time-course of the antifungal effects of the LCSs. The LCSs were harvested at 12, 24, 48 and 72 h after inoculation of Lactobacillus, and their anti-Candida activity was evaluated (Fig. 4C) . The LCS of L. fermentum SNUV175 collected at 12-48 h exhibited strong antifungal activity, while the LCS of L. crispatus SNUV220 collected from 24 h displayed antifungal activity. The antifungal effect of the LCSs was not affected by heat inactivation and proteolytic enzyme treatment (Fig. 4D) . Finally, the molecular weight of the antifungal molecule was estimated by 3 kDa molecular weight filtration (Fig. 4E) . The LCSs of both L. fermentum SNUV175 and L. crispatus SNUV220 still elicited an antifungal effect after filtration. These results suggest that the inhibitory effect of the LCSs is attributable to a neutral small molecule (less than 3 kDa) that is not affected by heat and proteolytic enzymes.
Inhibitory effect of neutral LCSs on hyphal growth. We investigated the effect of the LCSs from L. fermentum SNUV175 and L. crispatus SNUV220 on hyphal induction (Fig. 5A) . Incubation with neutral LCSs significantly suppressed hyphal growth in comparison with the vehicle control (Fig. 5B,C) . The pH-unadjusted acidic LCSs also inhibited hyphal growth well ( Supplementary Fig. S1 ). We further investigated hypha-related gene expression by qPCR. Consistently, treatment with the neutral LCSs significantly downregulated expression of hypha-related genes, such as ALS3, ECE1, SAP5 and HWP1 (Fig. 5D ).
Anti-Candida activity of a mixture of neutral LCss in a murine model of vulvovaginal candidiasis. We investigated the anti-Candida effect of a mixture of neutral LCSs from L. fermentum SNUV175 and L. crispatus SNUV220 in a murine model of vulvovaginal candidiasis (Fig. 6A) . The burden of C. albicans in the vagina was significantly decreased after treatment with this LCS mixture intravaginally for 2 weeks (Fig. 6B and www.nature.com/scientificreports www.nature.com/scientificreports/ Supplementary Fig. S3 ). Furthermore, histological evaluation revealed that C. albicans clearance was increased, consistent with the results obtained in vitro (Fig. 6C) .
Discussion
This study focused on isolation of vaginal lactobacilli that exhibit strong anti-Candida activity in vitro and in vivo. We first analysed the vaginal microbiota composition and lactobacilli species profiles of Korean women, and isolated 51 vaginal lactobacilli strains comprising four Lactobacillus species. We isolated four strains (L. fermentum, L. crispatus, L. jensenii and L. gasseri) in an unbiased manner. Their distribution was similar among the subjects. At the species level, the abundance of L. iners and L. crispatus was high in metagenome analysis. However, L. iners strains were not isolated. These findings were consistent among the subjects. The distribution of Lactobacillus species was similar in similar study 11 but depending on the disease states and isolation methods, various species of bacteria can be isolated from vagina fluid 12 . C. albicans growth was inhibited more by the majority of pH-unadjusted, acidic LCSs of L. crispatus than by those of other Lactobacillus species. The vaginal environment in humans is maintained at an acidic pH (4-4.5) via production of lactate by lactobacilli, and this is important to inhibit pathogen growth 13 . However, the acidic environment and dominance of lactobacilli are not sustained after menopause, and consequently post-menopausal women are more susceptible to diverse infections. The LCSs of L. fermentum strains exhibited potent anti-Candida www.nature.com/scientificreports www.nature.com/scientificreports/ activity when adjusted to neural pH and at their acidic naïve pH, suggesting that these strains produce antifungal molecules other than lactate 14 . A recent study reported that the culture supernatant of L. crispatus at low pH suppresses growth and hyphal growth of C. albicans in vitro 15 . Other lactobacilli species, including L. rhamnosus, L. reuteri and a mixture thereof, were reported to be vaginal probiotics that inhibit pathogen growth [16] [17] [18] . L. fermentum elicits broad inhibitory effects on Candida species 19 . In this study, L. fermentum and L. crispatus isolates inhibited C. albicans growth at neutral pH effectively in vitro assay and in vivo model. Moreover, the LCSs inhibited C. albicans morphogenesis to develop hyphae, which is a virulent form that causes vaginal inflammation 20, 21 . Hyphal growth was reported to be important for virulence of C. albicans [22] [23] [24] [25] [26] . The candidalysin peptide (ECE1) is only secreted by the hyphal form of C. albicans and induces lysis of mammalian cell membranes, inflammation and pathogenesis of vulvovaginal candidiasis 27, 28 . Expression of hyphal-related genes, such as ALS3, ECE1, SAP5 and HWP1, was significantly downregulated in the LCS-treated groups 29, 30 . ALS3 contributes to invasion of cells and cellular damage 21 . HWP1 encodes a cell wall mannose protein required for hyphal formation and adhesion to epithelial cells 31 . SAP5 encodes a member of the secreted aspartic protease family, which is important for the pathogenesis of candidiasis 32 . Expression of virulence genes is related to the pathogenesis of C. albicans infection. Therefore, the decrease in hypha-related genes is expected to alleviate cellular damage and inflammation induced by C. albicans.
Rodent models of vaginal infection do not completely mimic the vaginal environment of humans 33 . However, many murine models of vulvovaginal candidiasis have been reported 28, 34, 35 . A mixture of LCSs at neutral pH inhibited C. albicans growth in a murine vulvovaginal candidiasis model. This suggests that Lactobacillus strains can prevent candidiasis in the non-acidic vaginal environment by inhibiting growth and morphogenesis of Candida. We further investigated the biochemical traits of the anti-Candida compound produced by L. crispatus and L. fermentum. Antifungal activity at neutral pH was not affected by heat inactivation and proteolytic enzyme treatment. The compound responsible was less than 3 kDa in size and was produced by lactobacilli after the stationary phase. An antifungal protein was previously reported to inhibit hyphal growth 15 ; however, the antifungal compounds reported in that previous study and the current study appear to differ. Further research is required to extract the anti-Candida compound from LCS and to determine its molecular structure by bioassay-guided fractionation and comparative metabolite analysis. www.nature.com/scientificreports www.nature.com/scientificreports/ In summary, vaginal Lactobacillus strains isolated from healthy women produced a small molecule with anti-Candida activity in addition to lactate and inhibited growth and hyphal morphogenesis of C. albicans. We used three models to validate the anti-Candida effect of lactobacilli, namely, an in vitro assay, a hyphal growth assay and an in vivo model of vulvovaginal candidiasis. Our results suggest that resistance to vulvovaginal candidiasis is increased when L. crispatus and L. fermentum is the dominant bacterial community in the vaginal environment. The antifungal compound produced by vaginal Lactobacillus may reduce the burden of C. albicans infection. Future studies are required to elucidate the mechanism by which growth and hyphal transition of C. albicans are suppressed at the molecular level.
Methods
Isolation of vaginal Lactobacillus strains from healthy Korean subjects. Study subjects were recruited from the Healthy Twin Study as part of the Korean Genome Epidemiology Study 36 . All participants provided written informed consent to participate in this study. Samples were collected from three pairs of monozygotic twins and their mothers who underwent Papanicolaou smear tests at Samsung Medical Center (Seoul, Korea). The age of the nine subjects ranged from 25 to 79 years (Supplementary Table S3 ). Among the subjects, mothers (M) were post-menopausal and twins (T1 and T2) were pre-menopausal. None of the participants had any history of cervicovaginal disease and any genetic/metabolic diseases. Cervicovaginal samples were collected from the mid-vaginal wall during a speculum examination by clinicians using an ESwab (Copan Diagnostics Inc., Murrieta, CA, USA) 37 . The swabs were immediately stored in modified Liquid Amies solution, placed on ice and transported to the laboratory for microbiome analysis and lactobacilli isolation 38 . Lactobacillus species were isolated on to Rogosa medium(Oxoid Ltd, Basingstoke, Hampshire, UK), Brain-Heart infusion medium (Becton, Dickinson and Company, Baltimore, MD, USA, Columbia medium(Oxoid Ltd, Basingstoke, Hampshire, UK) and Chocolate medium (Oxoid Ltd, Basingstoke, Hampshire, UK)The study protocol was approved by the Korea Centers for Disease Control and the Institutional Review Board (IRB) of Samsung Medical Center (IRB No. 144-2011-07-11). All experiments were performed in accordance with relevant guidelines and regulations.
DNA extraction and 16S rRNA sequencing analysis. Total genomic DNA was extracted from vaginal swabs using a PowerSoil ® DNA Isolation Kit (MO BIO Laboratories, Inc., Carlsbad, CA, USA) according to the manufacturer's instructions with minor modifications 39 . Extracted nucleic acids were stored at −80 °C until use. The V4 region of the 16S rRNA gene was amplified using Illumina adaptor universal primers (515F/806R) and the 16S rRNA Amplification Protocol from the Earth Microbiome Project 40 . The PCR amplicon was purified using an UltraClean ® PCR Clean-Up Kit (MO BIO Laboratory, Inc., Carlsbad, CA, USA) and quantified using a Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies, Carlsbad, CA, USA). The samples were pooled and sequenced on a MiSeq platform with a 2 × 300 bp reagent kit (Illumina, San Diego, CA, USA) 41 . The generated reads underwent quality filtering and trimming using the FASTX-Toolkit. Sequence data were analysed using Quantitative Insights Into Microbial Ecology (QIIME) 1.5.0 (http://qiime.sourceforge.net) 42 . Open-reference operational taxonomic unit picking was performed at the 97% sequence similarity level with reference to the Measurement of lactate and H 2 o 2 production by Lactobacillus species and the pH of LCss. All isolates were identified by Sanger sequencing of the 16S rRNA target region (27F/1492R). Lactic acid production by Lactobacillus strains was investigated using EnzyChrom L-and D-lactate Assay kits (BioAssay Systems, Hayward, CA, USA). Lactobacillus strains isolated from the vagina were cultured in MRS broth medium and subsequently filter-sterilised. The lactate concentration in the LCS was measured in accordance with the manufacturer's instructions. The acidity of the LCS was measured using a benchtop pH meter (Thermo Fisher Scientific, Waltham, MA, USA). The ability of Lactobacillus strains to produce H 2 O 2 was evaluated as described by Rabe and Hillier 43 with minor modifications. All strains were cultured on MRS agar plates containing 25 mg of 3,3′,5,5′tetramethylbenzidine (Sigma-Aldrich, St. Louis, MO, USA), 0.5 mg of hemin and 0.05 µg of vitamin K (Sigma-Aldrich, St. Louis, MO, USA). The plates were incubated anaerobically at 37 °C for 48 h and then exposed to air for 30 min to check for a blue colour change. preparation of LCss. Lactobacilli were grown in MRS broth anaerobically at 37 °C for 48 h and then removed by centrifugation at 4,000 × g for 10 min at 4 °C. The pH of the LCS was measured and adjusted to neutral with 5 N sodium hydroxide. Thereafter, the LCS was passed through a 0.22 µm nitrocellulose filter (Advantec Manufacturing Inc, New Berlin, WI, USA). The filtrate was stored at −20 °C before use.
C. albicans growth inhibition assay. C. albicans was cultured in YPD broth for 18 h at 30 °C in a shaking incubator at 200 rpm, washed twice with 10 mM phosphate-buffered saline (PBS) at pH 7.4 and adjusted to a density of 2 × 10 6 cells/mL using PBS. Thereafter, 100 µL of LCS, 100 µL of YPD broth and 50 µL of C. albicans suspension were added to each well of a 96-well culture plate (SPL Life Sciences Co., Ltd., Pocheonsi, Gyeonggido, Korea). MRS broth was used as a control for LCS. The culture plate was incubated aerobically at 30 °C for 24 h. Growth of C. albicans was measured spectrophotometrically at 600 nm.
Hyphal growth inhibition assay. Hyphal growth was assessed based on hyphal length analysis 44 . C. albicans was cultured in YPD broth at 30 °C for 18 h in a shaking incubator at 200 rpm, washed twice with PBS and adjusted to a density of approximately 5 × 10 5 cells/mL using serum-free Roswell Park Memorial Institute (RPMI) 1640 medium. For hyphal growth analysis, 100 µL of C. albicans cell suspension, 700 µL of fresh RPMI 1640 medium and 200 µL of LCS (20% v/v) were mixed in a 24-well culture plate. The plate was incubated at 37 °C in 5% CO 2 for 3 h. Thereafter, the medium was removed, and C. albicans cells were fixed in 4% paraformaldehyde and stained with Calcofluor white (Sigma-Aldrich, St. Louis, MO, USA). Hyphae were imaged using an EVOS FL cell imaging system (Thermo Fisher Scientific, Waltham, MA, USA). Hyphal length was measured using ImageJ software (National Institutes of Health, Bethesda, MD, USA). All hyphal branches were included in length measurements.
RNA extraction and quantification of gene expression. For gene expression analysis, C. albicans was cultured in YPD medium at 30 °C for 18 h in a shaking incubator at 200 rpm, washed twice with PBS and resuspended in serum-free RPMI 1640 medium. Subsequently, 1 mL of C. albicans (1 × 10 7 cells), 7 mL of fresh RPMI 1640 medium and 2 mL of LCS (20% v/v) were mixed in a 100 mm 2 culture dish, and then incubated at 37 °C in 5% CO 2 for 3 h. Thereafter, the medium was removed, and C. albicans was rinsed with cold PBS, collected using a cell scraper, washed with 1 mL of cold PBS and centrifuged at 3,000 × g for 2 min at 4 °C. The supernatant was removed, and the cell pellet was stored at −80 °C prior to RNA extraction. RNA was extracted using a Yeastar ™ RNA Kit (Zymo Research, Irvine, CA, USA) according to the manufacturer's instructions. cDNA was synthesised using 500 µg of RNA as the template and a High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. cDNA samples were used for quantitative PCR with KAPA SYBR ® FAST qPCR Kit Master Mix (Kapa Biosystems, Wilmington, MA, USA). Amplification was performed using a Rotor Gene-Q system (Qiagen, Germantown, MD, USA). The PCR primer sequences are shown in Supplementary Table S1 . The ΔCt value was calculated using the ACT1 gene as an endogenous control and normalised against the MRS control to calculate the 2 −(∆∆Ct) value for statistical analysis.
Murine model of vulvovaginal candidiasis.
Experiments using the murine model of vulvovaginal candidiasis were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals issued by the Institutional Animal Care and Use Committee of Seoul National University, Faculty of Science (SNU-170801-7). The model of vaginal C. albicans infection was generated as described by Yano et al. 35 and Borghi et al. 34 with minor modifications. Briefly, 0.5 mg of β-estradiol 17-valerate (Sigma-Aldrich, St. Louis, MO, USA) diluted in 100 µL of sesame oil was administered intraperitoneally at 48 h before infection to maintain pseudo-estrous conditions and was administered weekly thereafter. LCS (20 µL) was administered intravaginally each day for 7 days pre-infection and 7 days post-infection with anaesthetics. C. albicans (5 × 10 6 cells/mL) prepared in 10 µL of PBS containing 1% low-melting agarose (Lonza, Basel, Switzerland) was administered intravaginally. At 7
